Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Risk stratification with exercise N(13)-ammonia PET in adults with anomalous right coronary arteries.

Cremer PC, Mentias A, Koneru S, Schoenhagen P, Majdalany D, Lorber R, Flamm SD, Hobbs RE, Pettersson G, Jaber WA.

Open Heart. 2016 Aug 22;3(2):e000490. doi: 10.1136/openhrt-2016-000490. eCollection 2016.

2.

Initial emergency department systolic blood pressure predicts left ventricular systolic function in acute decompensated heart failure.

Styron JF, Jois-Bilowich P, Starling R, Hobbs RE, Kontos MC, Pang PS, Peacock WF.

Congest Heart Fail. 2009 Jan-Feb;15(1):9-13. doi: 10.1111/j.1751-7133.2008.00047.x.

3.

Endogenous B-type natriuretic peptide: a limb of the regulatory response to acutely decompensated heart failure.

Hobbs RE, Mills RM.

Clin Cardiol. 2008 Sep;31(9):407-12. doi: 10.1002/clc.20304. Review.

4.

Vasopressin receptor antagonists in heart failure.

Hobbs RE, Tang WH.

Recent Pat Cardiovasc Drug Discov. 2006 Jun;1(2):177-84. Review.

PMID:
18232127
5.

The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation.

Yamani MH, Chuang HH, Ozduran V, Avery RK, Mawhorter SD, Cook DJ, Zilka C, Zeroske K, Buda T, Hobbs RE, Taylor DO, Smedira NG, Starling RC.

J Heart Lung Transplant. 2006 Jul;25(7):820-4. Epub 2006 May 30.

PMID:
16818125
6.

Therapeutic potential of nesiritide (recombinant b-type natriuretic peptide) in the treatment of heart failure.

Hobbs RE, Mills RM.

Expert Opin Investig Drugs. 1999 Jul;8(7):1063-72.

PMID:
15992106
7.

Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation.

Tuzcu EM, Kapadia SR, Sachar R, Ziada KM, Crowe TD, Feng J, Magyar WA, Hobbs RE, Starling RC, Young JB, McCarthy P, Nissen SE.

J Am Coll Cardiol. 2005 May 3;45(9):1538-42.

8.

Images in cardiovascular medicine. A "mickey mouse" coronary anomaly: aorto-left atrial fistula with aneurysm.

Chacko M, Lytle BW, White RD, Hobbs RE.

Circulation. 2005 Mar 29;111(12):e162-3. No abstract available.

PMID:
15795356
9.

Current and future uses of nesiritide.

Hobbs RE, Tang W.

Future Cardiol. 2005 Mar;1(2):145-55. doi: 10.1517/14796678.1.2.145.

PMID:
19804159
10.

Management of decompensated heart failure.

Hobbs RE.

Am J Ther. 2004 Nov-Dec;11(6):473-9. Review.

PMID:
15543088
11.

Guidelines for the diagnosis and management of heart failure.

Hobbs RE.

Am J Ther. 2004 Nov-Dec;11(6):467-72. Review.

PMID:
15543087
12.

Drug treatment of patients with decompensated heart failure.

Mills RM, Hobbs RE.

Am J Cardiovasc Drugs. 2001;1(2):119-25. Review.

PMID:
14728041
13.

Nesiritide in perspective: evolving approaches to the management of acute decompensated heart failure.

Mills RM, Hobbs RE.

Drugs Today (Barc). 2003 Oct;39(10):767-74. Review.

PMID:
14668932
14.

Repeated intravascular ultrasound imaging in cardiac transplant recipients does not accelerate transplant coronary artery disease.

Ramasubbu K, Schoenhagen P, Balghith MA, Brechtken J, Ziada KM, Kapadia SR, Hobbs RE, Rincon G, Nissen SE, Tuzcu EM.

J Am Coll Cardiol. 2003 May 21;41(10):1739-43.

15.

Early constriction or expansion of the external elastic membrane area determines the late remodeling response and cumulative lumen loss in transplant vasculopathy: an intravascular ultrasound study with 4-year follow-up.

Tsutsui H, Schoenhagen P, Ziada KM, Crowe TD, Klingensmith JD, Vince DG, Bott-Silverman C, Starling R, Hobbs RE, Young J, Nissen SE, Tuzcu EM.

J Heart Lung Transplant. 2003 May;22(5):519-25.

PMID:
12742413
16.

Using BNP to diagnose, manage, and treat heart failure.

Hobbs RE.

Cleve Clin J Med. 2003 Apr;70(4):333-6.

PMID:
12701987
17.

"BNP" for heart failure: role of nesiritide in cardiovascular therapeutics.

Mills RM, Hobbs RE, Young JB.

Congest Heart Fail. 2002 Sep-Oct;8(5):270-3. Review.

18.

How to use nesiritide in treating decompensated heart failure.

Mills RM, Hobbs RE.

Cleve Clin J Med. 2002 Mar;69(3):252-6. Review.

PMID:
11890216
19.

Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study.

Tsutsui H, Ziada KM, Schoenhagen P, Iyisoy A, Magyar WA, Crowe TD, Klingensmith JD, Vince DG, Rincon G, Hobbs RE, Yamagishi M, Nissen SE, Tuzcu EM.

Circulation. 2001 Aug 7;104(6):653-7.

PMID:
11489770
20.

High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound.

Tuzcu EM, Kapadia SR, Tutar E, Ziada KM, Hobbs RE, McCarthy PM, Young JB, Nissen SE.

Circulation. 2001 Jun 5;103(22):2705-10.

PMID:
11390341
21.

Should patients with severe heart failure be treated with beta blockers?

Hobbs RE.

Cleve Clin J Med. 2001 May;68(5):469-70. No abstract available.

PMID:
11352327
22.

An update on nesiritide for treatment of decompensated heart failure.

Hobbs RE, Mills RM, Young JB.

Expert Opin Investig Drugs. 2001 May;10(5):935-42. Review.

PMID:
11322867
23.

Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection.

Yamani MH, Avery RK, Mawhorter SD, Young JB, Ratliff NB, Hobbs RE, McCarthy PM, Smedira NG, Goormastic M, Pelegrin D, Starling RC.

J Heart Lung Transplant. 2001 Apr;20(4):425-30.

PMID:
11295580
24.

Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study.

Jimenez J, Kapadia SR, Yamani MH, Platt L, Hobbs RE, Rincon G, Botts-Silverman C, Starling RC, Young JB, Nissen SE, Tuzcu M, Ratliff NB.

J Heart Lung Transplant. 2001 Apr;20(4):393-8. Erratum in: J Heart Lung Transplant 2001 Jul;20(7):803.

PMID:
11295576
25.

Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation.

Eisen HJ, Hobbs RE, Davis SF, Carrier M, Mancini DM, Smith A, Valantine H, Ventura H, Mehra M, Vachiery JL, Rayburn BK, Canver CC, Laufer G, Costanzo MR, Copeland J, Dureau G, Frazier OH, Dorent R, Hauptman PJ, Kells C, Masters R, Michaud JL, Paradis I, Renlund DG, Vanhaecke J, Mellein B, Mueller EA.

Transplantation. 2001 Jan 15;71(1):70-8.

PMID:
11211198
26.

Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection.

Yamani MH, Starling RC, Pelegrin D, Platt L, Majercik M, Hobbs RE, McCarthy P, Young JB.

J Heart Lung Transplant. 2000 Apr;19(4):337-42.

PMID:
10775813
27.

Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging.

Kapadia SR, Ziada KM, L'Allier PL, Crowe TD, Rincon G, Hobbs RE, Bott-Silverman C, Young JB, Nissen SE, Tuzcu EM.

J Heart Lung Transplant. 2000 Feb;19(2):167-72.

PMID:
10703693
28.

Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation.

Eisen HJ, Hobbs RE, Davis SF, Laufer G, Mancini DM, Renlund DG, Valantine H, Ventura H, Vachiery JL, Bourge RC, Canver CC, Carrier M, Costanzo MR, Copeland J, Dureau G, Frazier OH, Dorent R, Hauptman PJ, Kells C, Master R, Michaud JL, Paradis I, Smith A, Vanhaecke J, Mueller EA, et al.

Transplantation. 1999 Sep 15;68(5):663-71.

PMID:
10507486
29.

Chronic coronary artery dissection presenting as heart failure.

Hobbs RE, Scally AP, Tan WA.

Circulation. 1999 Jul 27;100(4):445. No abstract available.

PMID:
10421607
30.

Microsporidia infection in transplant patients.

Gumbo T, Hobbs RE, Carlyn C, Hall G, Isada CM.

Transplantation. 1999 Feb 15;67(3):482-4. Review.

PMID:
10030299
31.

Development of transplantation vasculopathy and progression of donor-transmitted atherosclerosis: comparison by serial intravascular ultrasound imaging.

Kapadia SR, Nissen SE, Ziada KM, Guetta V, Crowe TD, Hobbs RE, Starling RC, Young JB, Tuzcu EM.

Circulation. 1998 Dec 15;98(24):2672-8.

PMID:
9851952
32.

Results of the ATLAS study. High or low doses of ACE inhibitors for heart failure?

Hobbs RE.

Cleve Clin J Med. 1998 Nov-Dec;65(10):539-42.

PMID:
9830787
33.

One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology.

McCarthy PM, Smedira NO, Vargo RL, Goormastic M, Hobbs RE, Starling RC, Young JB.

J Thorac Cardiovasc Surg. 1998 Apr;115(4):904-12.

34.

Significance of positive cultures from donor left atrium and postpreservation fluid in heart transplantation.

Mossad SB, Avery RK, Goormastic M, Hobbs RE, Stewart RW.

Transplantation. 1997 Oct 27;64(8):1209-10.

PMID:
9355844
35.

The incremental risk of female sex in heart transplantation: a multiinstitutional study of peripartum cardiomyopathy and pregnancy. Cardiac Transplant Research Database Group.

Johnson MR, Naftel DC, Hobbs RE, Kobashigawa JA, Pitts DE, Levine TB, Tolman D, Bhat G, Kirklin JK, Bourge RC.

J Heart Lung Transplant. 1997 Aug;16(8):801-12.

PMID:
9286772
36.

Does distance between home and transplantation center adversely affect patient outcomes after heart transplantation?

Rodkey SM, Hobbs RE, Goormastic M, Young JB.

J Heart Lung Transplant. 1997 May;16(5):496-503.

PMID:
9171267
37.
38.

Permanent mechanical circulatory support with an implantable left ventricular assist device.

McCarthy PM, Young JB, Smedira NG, Hobbs RE, Vargo RL, Starling RC.

Ann Thorac Surg. 1997 May;63(5):1458-61.

PMID:
9146345
39.
40.

Bench repair of donor mitral valve before heart transplantation.

Massad MG, Smedira NG, Hobbs RE, Hoercher K, Vandervoort P, McCarthy PM.

Ann Thorac Surg. 1996 Jun;61(6):1833-5.

PMID:
8651799
41.

Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study.

Smart FW, Naftel DC, Costanzo MR, Levine TB, Pelletier GB, Yancy CW Jr, Hobbs RE, Kirklin JK, Bourge RC.

J Heart Lung Transplant. 1996 Apr;15(4):329-41.

PMID:
8732591
42.

Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: insights from systematic intravascular ultrasound imaging.

Tuzcu EM, De Franco AC, Goormastic M, Hobbs RE, Rincon G, Bott-Silverman C, McCarthy P, Stewart R, Mayer E, Nissen SE.

J Am Coll Cardiol. 1996 Mar 15;27(4):839-46.

43.

Implantable LVAD infections: implications for permanent use of the device.

McCarthy PM, Schmitt SK, Vargo RL, Gordon S, Keys TF, Hobbs RE.

Ann Thorac Surg. 1996 Jan;61(1):359-65; discussion 372-3.

PMID:
8561605
44.

Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure.

James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, Bravo E.

Circulation. 1995 Nov 1;92(9 Suppl):II191-5.

PMID:
7586406
45.

The prevalence of coronary artery disease in liver transplant candidates over age 50.

Carey WD, Dumot JA, Pimentel RR, Barnes DS, Hobbs RE, Henderson JM, Vogt DP, Mayes JT, Westveer MK, Easley KA.

Transplantation. 1995 Mar 27;59(6):859-64.

PMID:
7701580
46.

Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound.

Tuzcu EM, Hobbs RE, Rincon G, Bott-Silverman C, De Franco AC, Robinson K, McCarthy PM, Stewart RW, Guyer S, Nissen SE.

Circulation. 1995 Mar 15;91(6):1706-13.

PMID:
7882477
47.

Hemodynamic and physiologic changes during support with an implantable left ventricular assist device.

McCarthy PM, Savage RM, Fraser CD, Vargo R, James KB, Goormastic M, Hobbs RE.

J Thorac Cardiovasc Surg. 1995 Mar;109(3):409-17; discussion 417-8.

48.

Flow cytometry crossmatching: a method for monitoring antidonor antibodies in heart transplant recipients.

Hurley JP, Cook DJ, McCarthy PM, Hobbs RE, Koo AP, Ratliff NB, Klingman LL, Mrzena K, Stewart RW.

Transplant Proc. 1995 Feb;27(1):1301-2. No abstract available.

PMID:
7878891
49.

Congestive heart failure.

Hobbs RE, Czerska B.

Postgrad Med. 1994 Nov;96(5):167-172. doi: 10.1080/00325481.1994.11945915.

PMID:
29219702
50.

Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.

McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Hobbs RE, Pashkow FJ.

Circulation. 1994 Nov;90(5 Pt 2):II83-6.

PMID:
7955290

Supplemental Content

Loading ...
Support Center